Overview

Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Tacrolimus pharmacokinetics study in primary living donor liver transplantation patients with Tacrolimus based immunosuppressive regimens.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Astellas Pharma Korea, Inc.
Treatments:
Tacrolimus